NCT01519700 Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim Status COMPLETED Phase PHASE3
NCT01509300 HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT01467115 Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01445821 Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Status TERMINATED Phase PHASE3
NCT01415765 MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01413100 Scleroderma Treatment With Autologous Transplant (STAT) Study Status COMPLETED Phase PHASE2
NCT01408043 Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma Status TERMINATED Phase NA
NCT01366183 Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Status UNKNOWN Phase N/A
NCT01339572 Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation Status COMPLETED Phase PHASE2
NCT01318317 Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01301963 Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide Status TERMINATED Phase PHASE3
NCT01266447 Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT01256398 Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01222819 SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients Status TERMINATED Phase PHASE4
NCT01196715 Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes Status COMPLETED Phase PHASE3
NCT01194934 NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01177683 Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01172912 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Status UNKNOWN Phase PHASE2